FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. ULS
8. AWK
9. DRI
10. USO

Go back to FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1183.46 +1.57 (0.13%)
Previous Close $1181.89    52 Week High $88.16 
Open $1185.32    52 Week Low $67.88 
Day High $1190.00    P/E 273.95 
Day Low $1160.84    EPS $4.32 
Volume 1,924,379